TGFB1 and fatty liver disease: Our findings reveal that hepatic steatosis patients exhibit a distinct biosignature of biochemical parameters, and that TGF-β is an important biomarker that could help evaluate individuals with hepatic steatosis, in association with other non-invasive techniques such as ultrasound.